Skip to main content

Research Repository

Advanced Search

Outputs (101)

Alcohol-attributable healthcare attendances up to 10 years prior to diagnosis of alcoholic cirrhosis: a population based case-control study (2015)
Journal Article
Otete, H. E., Orton, E., Fleming, K. M., & West, J. (2016). Alcohol-attributable healthcare attendances up to 10 years prior to diagnosis of alcoholic cirrhosis: a population based case-control study. Liver International, 36(4), 538-546. https://doi.org/10.1111/liv.13002

BACKGROUND & AIMS:
Cirrhosis because of alcohol could be avoided if drinking behaviour could be altered earlier in the disease course. Our aim was to quantify the burden of morbidities in patients prior to alcoholic cirrhosis diagnosis, as this may... Read More about Alcohol-attributable healthcare attendances up to 10 years prior to diagnosis of alcoholic cirrhosis: a population based case-control study.

Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial: Oral Glutamine Supplementation in Cystic Fibrosis (2015)
Journal Article
Forrester, D. L., Knox, A. J., Smyth, A. R., Barr, H. L., Simms, R., Pacey, S. J., Pavord, I. D., Honeybourne, D., Dewar, J., Clayton, A., & Fogarty, A. W. (2016). Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial: Oral Glutamine Supplementation in Cystic Fibrosis. Pediatric Pulmonology, 51(3), 253-257. https://doi.org/10.1002/ppul.23370

Rationale: Pulmonary infection and malnutrition in cystic fibrosis are associated with decreased survival. Glutamine has a possible anti-microbial effect, with a specific impact against Pseudomonas aeruginosa. We aimed to test the hypothesis that ora... Read More about Glutamine supplementation in cystic fibrosis: A randomized placebo-controlled trial: Oral Glutamine Supplementation in Cystic Fibrosis.

Pharmacological interventions for promoting smoking cessation during pregnancy (2015)
Journal Article
Coleman, T., Chamberlain, C., Davey, M.-A., Cooper, S., & Leonardi-Bee, J. (2015). Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews, https://doi.org/10.1002/14651858.CD010078.pub2

Background

Smoking in pregnancy is a public health problem. When used by non-pregnant smokers, pharmacotherapies (nicotine replacement therapy (NRT), bupropion and varenicline) are effective for smoking cessation, however, their efficacy and safet... Read More about Pharmacological interventions for promoting smoking cessation during pregnancy.

Impact of gout on the risk of atrial fibrillation (2015)
Journal Article
Kuo, C.-F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2016). Impact of gout on the risk of atrial fibrillation. Rheumatology, 55(4), 721-728. https://doi.org/10.1093/rheumatology/kev418

OBJECTIVES: To examine the risk of atrial fibrillation (AF) at the time of first diagnosis of gout compared with matched controls and to follow incident gout patients and their matched controls after diagnosis to compare their subsequent risk of AF.... Read More about Impact of gout on the risk of atrial fibrillation.

Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study (2015)
Journal Article
Dallywater, W., Powell, H. A., Hubbard, R. B., & Navaratnam, V. (in press). Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study. Chest, 147(1), https://doi.org/10.1378/chest.14-0041

OBJECTIVE: People with idiopathic pulmonary fibrosis (IPF) have been shown to be at an increased risk for cardiovascular (CV) disease, but reasons for this are unknown. The aim of this study was to compare the prevalence of common CV risk factors in... Read More about Risk factors for cardiovascular disease in people with idiopathic pulmonary fibrosis: a population-based study.

Challenges to the surveillance of non-communicable diseases – a review of selected approaches (2015)
Journal Article
Kroll, M., Phalkey, R. K., & Kraas, F. (2015). Challenges to the surveillance of non-communicable diseases – a review of selected approaches. BMC Public Health, 15, https://doi.org/10.1186/s12889-015-2570-z

Background: The rising global burden of non-communicable diseases (NCDs) necessitates the institutionalization of surveillance systems to track trends and evaluate interventions. However, NCD surveillance capacities vary across high- and low- and mid... Read More about Challenges to the surveillance of non-communicable diseases – a review of selected approaches.

Comorbidities in patients with gout prior to and following diagnosis: case-control study (2015)
Journal Article
Kuo, C.-F., Grainge, M. J., Mallen, C., Zhang, W., & Doherty, M. (2016). Comorbidities in patients with gout prior to and following diagnosis: case-control study. Annals of the Rheumatic Diseases, 75(1), https://doi.org/10.1136/annrheumdis-2014-206410

OBJECTIVES: To determine the burden of comorbidities in patients with gout at diagnosis and the risk of developing new comorbidities post diagnosis.

METHODS: There were 39 111 patients with incident gout and 39 111 matched controls identified fro... Read More about Comorbidities in patients with gout prior to and following diagnosis: case-control study.

Small area synthetic estimates of smoking prevalence during pregnancy in England (2015)
Journal Article
Szatkowski, L., Fahy, S., Coleman, T., Taylor, J., Twigg, L., Moon, G., & Leonardi-Bee, J. (2015). Small area synthetic estimates of smoking prevalence during pregnancy in England. Population Health Metrics, 13(34), https://doi.org/10.1186/s12963-015-0067-8

Background: Complete and accurate data on maternal smoking prevalence during pregnancy are not available at a local geographical scale in England. We employ a synthetic estimation approach to predict the expected prevalence of smoking during pregnanc... Read More about Small area synthetic estimates of smoking prevalence during pregnancy in England.

In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011 (2015)
Journal Article
Hutchinson, J. P., Fogarty, A. W., McKeever, T. M., & Hubbard, R. B. (2016). In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011. American Journal of Respiratory and Critical Care Medicine, 193(10), 1161-1167. https://doi.org/10.1164/rccm.201508-1632OC

Rationale: Surgical lung biopsy can help to determine a specific diagnosis in interstitial lung disease, but has associated risks. Most currently available mortality data are derived from case series and may not be generalizable to broader population... Read More about In-hospital mortality following surgical lung biopsy for interstitial lung disease in the USA: 2000-2011.

The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control (2015)
Journal Article
Killingley, B., Killingley, B., Greatorex, J., Digard, P., Wise, H., Garcia, F., Varsani, H., Cauchemez, S., Enstone, J. E., Hayward, A., Curran, M. D., Read, R., Lim, W. S., Nicholson, K. G., & Nguyen-Van-Tam, J. S. (2016). The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control. Journal of Infection and Public Health, 9(3), 278-288. https://doi.org/10.1016/j.jiph.2015.10.009

In a multi-center, prospective, observational study over two influenza seasons, we sought to quantify and correlate the amount of virus recovered from the nares of infected subjects with that recovered from their immediate environment in community an... Read More about The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: Implications for infection prevention and control.